Patents by Inventor Michael Gerard Kelly

Michael Gerard Kelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1-aryl- or 1-alkylsulfony-heterocyclybenzazoles as 5-hydroxytryptamine-6 ligands
    Publication number: 20040087595
    Abstract: The present invention provides a compound of formula I and the use thereof in the therapeutic treatment of disorders related to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: December 4, 2003
    Publication date: May 6, 2004
    Applicant: Wyeth
    Inventors: Michael Gerard Kelly, Derek Cecil Cole
  • 1-Aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
    Publication number: 20040087637
    Abstract: The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: October 29, 2003
    Publication date: May 6, 2004
    Applicant: Wyeth
    Inventors: Ping Zhou, Michael Gerard Kelly
  • Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
    Patent number: 6727270
    Abstract: The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
    Type: Grant
    Filed: February 13, 2003
    Date of Patent: April 27, 2004
    Assignee: Wyeth
    Inventors: Michael Gerard Kelly, Ping Zhou
  • 1-aryl- or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
    Patent number: 6710069
    Abstract: The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
    Type: Grant
    Filed: December 9, 2002
    Date of Patent: March 23, 2004
    Assignee: Wyeth
    Inventors: Ping Zhou, Michael Gerard Kelly
  • Chroman derivatives as 5-hydroxytryptamine-6 ligands
    Patent number: 6706757
    Abstract: The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
    Type: Grant
    Filed: October 2, 2002
    Date of Patent: March 16, 2004
    Assignee: Wyeth
    Inventors: Lynne Padilla Greenblatt, Michael Gerard Kelly
  • Indolylalkylidenehydrazine-carboximidamide derivatives as 5-hydroxytryptamine-6 ligands
    Publication number: 20040002527
    Abstract: The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of a disorder relating to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: May 9, 2003
    Publication date: January 1, 2004
    Applicant: Wyeth
    Inventors: Derek Cecil Cole, Michael Gerard Kelly, David Scott Nunn, Lynne Padilla Greenblatt
  • (1-Substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
    Publication number: 20030232843
    Abstract: The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of a disorder relating to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: May 9, 2003
    Publication date: December 18, 2003
    Applicant: Wyeth
    Inventors: Derek Cecil Cole, Michael Gerard Kelly, Byron Abel Bravo, Yvette Latko Palmer
  • Heterocyclylalkylindole or-azaindole compounds as 5-hydroxytryptamine-6 ligands
    Publication number: 20030225121
    Abstract: The present invention provides a compound of formula I and the use thereof in the therapeutic treatment of disorders related to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: May 20, 2003
    Publication date: December 4, 2003
    Applicant: Wyeth
    Inventors: Ping Zhou, Michael Gerard Kelly, Yanfang Li
  • Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
    Publication number: 20030203895
    Abstract: The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: February 13, 2003
    Publication date: October 30, 2003
    Applicant: Wyeth
    Inventors: Michael Gerard Kelly, Ping Zhou
  • Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands
    Patent number: 6638972
    Abstract: The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
    Type: Grant
    Filed: October 3, 2002
    Date of Patent: October 28, 2003
    Assignee: Wyeth
    Inventors: Michael Gerard Kelly, Lynne Padilla Greenblatt, Gan Zhang, Yvette L. Palmer, Steven Edward Lenicek
  • Heterocyclylaklylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands
    Patent number: 6613781
    Abstract: The present invention provides a compound of formula I and the use thereof in the therapeutic treatment of disorders related to or affected by the 5-HT6 receptor
    Type: Grant
    Filed: December 20, 2001
    Date of Patent: September 2, 2003
    Assignee: Wyeth
    Inventors: Ping Zhou, Michael Gerard Kelly, Yanfang Li
  • Chroman derivatives as 5-hydroxytrytamine-6 ligands
    Publication number: 20030158175
    Abstract: The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: October 2, 2002
    Publication date: August 21, 2003
    Applicant: Wyeth
    Inventors: Lynne Padilla Greenblatt, Michael Gerard Kelly
  • Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands
    Publication number: 20030153599
    Abstract: The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: October 3, 2002
    Publication date: August 14, 2003
    Applicant: Wyeth
    Inventors: Michael Gerard Kelly, Lynne Padilla Greenblatt, Gan Zhang, Yvette L. Palmer, Steven Edward Lenicek
  • 1-aryl- or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
    Publication number: 20030149018
    Abstract: The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: December 9, 2002
    Publication date: August 7, 2003
    Applicant: Wyeth
    Inventors: Ping Zhou, Michael Gerard Kelly
  • 1-aryl or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
    Patent number: 6509357
    Abstract: The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
    Type: Grant
    Filed: January 22, 2002
    Date of Patent: January 21, 2003
    Assignee: Wyeth
    Inventors: Ping Zhou, Michael Gerard Kelly
  • Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
    Publication number: 20020198213
    Abstract: The present invention provides a compound of formula I and the use thereof in the therapeutic treatment of disorders related to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: December 20, 2001
    Publication date: December 26, 2002
    Applicant: American Home Products Corporation
    Inventors: Ping Zhou, Derek Cecil Cole, Michael Gerard Kelly, William Joseph Lennox
  • Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands
    Publication number: 20020128477
    Abstract: The present invention provides a compound of formula I and the use thereof in the therapeutic treatment of disorders related to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: December 20, 2001
    Publication date: September 12, 2002
    Applicant: American Home Products Corporation
    Inventors: Ping Zhou, Michael Gerard Kelly, Yanfang Li
  • 1-Aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
    Publication number: 20020115670
    Abstract: The present invention provides a compound of formula I and the use thereof in the therapeutic treatment of disorders related to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: November 1, 2001
    Publication date: August 22, 2002
    Applicant: American Home Products Corporation
    Inventors: Michael Gerard Kelly, Derek Cecil Cole
  • Trisubstituted-oxazole derivatives as serotonin ligands
    Patent number: 6242448
    Abstract: Compounds of the formula are useful for the treatment of anxiety, depression and related CNS disorders and other conditions such as the treatment of alcohol and drug withdrawal, sexual dysfunction and Alzheimer's disease.
    Type: Grant
    Filed: December 13, 1999
    Date of Patent: June 5, 2001
    Assignee: American Home Products Corporation
    Inventors: Michael Gerard Kelly, Lynne Padilla Greenblatt, Frances Christy Nelson
  • Piperazine derivatives
    Patent number: 5723464
    Abstract: Compounds are disclosed which have the general formula A: ##STR1## where R.sup.a and R.sup.b are each hydrogen or methyl and R.sup.c is hydrogen, halo or C.sub.1-4 alkyl optionally in the form of a pharmaceutically acceptable acid addition salt. The compounds are useful in the treatment of CNS disorders.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: March 3, 1998
    Assignee: American Home Products Corporation
    Inventors: Christopher Ian Brightwell, Michael Gerard Kelly